Insight Molecular Diagnostics (IMDX) Non Operating Investment Income (2018 - 2023)
Insight Molecular Diagnostics (IMDX) posted Non Operating Investment Income of -$69000.0 for Q4 2023, up 22.47% sequentially from -$89000.0 in Q3 2023, and down 592.86% YoY from $14000.0 in Q4 2022.
Insight Molecular Diagnostics (IMDX) Non Operating Investment Income (2018 - 2023) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 6 years of Non Operating Investment Income data on file, last reported at -$69000.0 in Q4 2023.
- Quarterly Non Operating Investment Income fell 592.86% year-over-year to -$69000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$61000.0 (up 87.05% YoY) and the FY2023 annual result came in at -$61000.0, up 87.05% from the prior year.
- Non Operating Investment Income improved to -$69000.0 in Q4 2023 per IMDX's latest filing, from -$89000.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $315000.0 in Q4 2020, with the low at -$330000.0 in Q1 2022.
- Average Non Operating Investment Income over 5 years is -$2700.0, with a median of -$21500.0 recorded in 2021.
- The widest YoY moves for Non Operating Investment Income: up 981.25% in 2021, down 790.0% in 2021.
- Insight Molecular Diagnostics' Non Operating Investment Income stood at -$36000.0 in 2019, then surged by 975.0% to $315000.0 in 2020, then sank by 106.03% to -$19000.0 in 2021, then soared by 173.68% to $14000.0 in 2022, then slumped by 592.86% to -$69000.0 in 2023.
- Business Quant data shows IMDX's Non Operating Investment Income at -$69000.0 in Q4 2023, -$89000.0 in Q3 2023, and -$24000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -69,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Sep 30, 2023 | -89,000.00 |
| Sep 30, 2023 | -89,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | -160,000.00 |
| Sep 30, 2022 | -160,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Sep 30, 2021 | -138,000.00 |
| Sep 30, 2021 | -138,000.00 |